DxNow

Portable Bio-imaging Systems & Microfluidic-Based Consumables

Industry

Digital Health

Founded

2013

Size

12 employees

Funding

$172,000

About

DxNow develops portable bio-imaging systems based on microfluidic technology based consumables for application in life science industry. The technology is based on the proprietary technology developed in Demirci Bio-Acoustic MEMS in Medicine Labs (BAMM Labs) at Harvard Medical School/Brigham & Women’s Hospital and Stanford Medicine. The company's product line includes CE marked FERTILE (Microfluidic sperm sorting chips) for ICSI and FERTILE PLUS for ICSI, IUI and IVF, CSI-Q, a Chip-based sperm identification and quantitation cartridges, and NGDE (Next-Generation Differential Extraction) system.

Funding

Amount $172,000
Investor Conventional Debt
Date September 11, 2014